A citation-based method for searching scientific literature

Jaewon Min, Woodring E Wright, Jerry W Shay. Nucleic Acids Res 2017
Times Cited: 31



Christopher M Heaphy, Andrea P Subhawong, Seung-Mo Hong, Michael G Goggins, Elizabeth A Montgomery, Edward Gabrielson, George J Netto, Jonathan I Epstein, Tamara L Lotan, William H Westra, Ie-Ming Shih, Christine A Iacobuzio-Donahue, Anirban Maitra, Qing K Li, Charles G Eberhart, Janis M Taube, Dinesh Rakheja, Robert J Kurman, T C Wu, Richard B Roden, Pedram Argani, Angelo M De Marzo, Luigi Terracciano, Michael Torbenson, Alan K Meeker. Am J Pathol 2011
Times Cited: 288




List of shared articles



Times cited

Resolving Roadblocks to Telomere Replication.
Emily Mason-Osann, Himabindu Gali, Rachel Litman Flynn. Methods Mol Biol 2019
7

ALT: A Multi-Faceted Phenomenon.
Aurore Sommer, Nicola J Royle. Genes (Basel) 2020
5

Alternative Lengthening of Telomeres in Pediatric Cancer: Mechanisms to Therapies.
Thomas Kent, Deanne Gracias, Samuel Shepherd, David Clynes. Front Oncol 2020
7


Targeting telomerase for cancer therapy.
Adam N Guterres, Jessie Villanueva. Oncogene 2020
16

Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells.
Mindy K Graham, Jiyoung Kim, Joseph Da, Jacqueline A Brosnan-Cashman, Anthony Rizzo, Javier A Baena Del Valle, Lionel Chia, Michael Rubenstein, Christine Davis, Qizhi Zheng,[...]. Mol Cancer Res 2019
9

ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner.
Jacqueline A Brosnan-Cashman, Ming Yuan, Mindy K Graham, Anthony J Rizzo, Kaylar M Myers, Christine Davis, Rebecca Zhang, David M Esopi, Eric H Raabe, Charles G Eberhart,[...]. PLoS One 2018
19


Diagnosis and treatment of ALT tumors: is Trabectedin a new therapeutic option?
Luca Pompili, Carlo Leonetti, Annamaria Biroccio, Erica Salvati. J Exp Clin Cancer Res 2017
19